A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer.

Yoshihiro HattoriYuko KonoShoichi ItohTakako InoueYoshiko UrataYoshitaka KawaRie TohnaiToru KumagaiKazumi NishinoRyuji UozumiSatoshi MoritaShunichi NegoroFumio ImamuraMiyako Satouchi

Published in: BMC cancer (2020)

UMIN Clinical Trials Registry: UMIN000011776; Date of registration: 17 September 2013; Date of enrolment of the first participant to the trial: 23 January 2014.

Keyphrases

advanced non small cell lung cancer
clinical trial
epidermal growth factor receptor
phase iii
phase ii
study protocol
health insurance
randomized controlled trial
locally advanced
tyrosine kinase
open label
double blind